
FDA approves GSK's bepirovirsen for chronic hepatitis B after a 19% functional cure rate, raising oligonucleotide scale-up stakes for manufacturers.
FDA specifies the DUNS UFI system for registration of domestic and foreign drug establishments.
FDA has
Source:






